Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
Opioid WithdrawalOpioid Use Disorder
Interventions
DEVICE

EmbracePlus Smartwatch

"The EmbracePlus is worn on the user's wrist and continuously collects raw data via specific sensors. These data can be wirelessly transmitted to a paired mobile device. The data received are analyzed by EmpaDSP, which computes the user physiological parameters. The Care App is responsible for transmitting raw data, device information, Care App-specific information, and computed physiological parameters to the Empatica Cloud. The device supports continuous data collection for monitoring of the following physiological parameters:~* Peripheral skin temperature~* Electrodermal activity~* Blood Oxygen Saturation under no motion conditions~* Activity associated with movement during sleep.~The EmbracePlus Watch has been used in previous human subject research studies for bio-physiological data collection in other medical conditions and have confirmed that there is minimal risk to participants. This device is therefore exempt from any IDE requirements."

DEVICE

Corti Sensor

"The Corti Wearable is a sweat sensor that is worn continuously measure cortisol, melatonin, tumor necrosis alpha interleukin-6 (IL-6) in the protein analytes in the sweat of participants via electrochemical impedance spectroscopy. The Corti Wearable comprises a plastic reader and a replaceable polymer sweat-sensing strip with zinc oxide (ZnO) coated electrodes that is worn on the participant's forearm. It is manufactured through a screen-printing technique that allows for an affinity-based interaction between a capture probe antibody and the target molecule generating electrochemical activity.~The Cort Wearable has been used in previous human subject research studies for bio-physiological data collection in other medical conditions and have confirmed that there is minimal risk to participants. This device is therefore exempt from any IDE requirements."

Trial Locations (2)

43201

ACTIVE_NOT_RECRUITING

Battelle Memorial Institute, Columbus

55012

RECRUITING

Hazelden Betty Ford Foundation, Center City

All Listed Sponsors
collaborator

Battelle Memorial Institute

OTHER

collaborator

Hazelden Betty Ford Foundation

UNKNOWN

collaborator

National Institutes of Health (NIH)

NIH

lead

Spark Biomedical, Inc.

INDUSTRY